These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 31009876)
21. Evaluation of the three most commonly used analytical methods for determination of inorganic arsenic and its metabolites in urine. Lindberg AL; Goessler W; Grandér M; Nermell B; Vahter M Toxicol Lett; 2007 Feb; 168(3):310-8. PubMed ID: 17174488 [TBL] [Abstract][Full Text] [Related]
22. Clinical pharmacokinetic study of arsenic trioxide in an acute promyelocytic leukemia (APL) patient: speciation of arsenic metabolites in serum and urine. Fukai Y; Hirata M; Ueno M; Ichikawa N; Kobayashi H; Saitoh H; Sakurai T; Kinoshita K; Kaise T; Ohta S Biol Pharm Bull; 2006 May; 29(5):1022-7. PubMed ID: 16651738 [TBL] [Abstract][Full Text] [Related]
23. On-line reversed-phase liquid chromatography hydride generation emission spectrometry: speciation of arsenic in urine of patients intravenously treated with As2O3. Do B; Alet P; Pradeau D; Poupon J; Guilley-Gaillot M; Guyon F J Chromatogr B Biomed Sci Appl; 2000 Apr; 740(2):179-86. PubMed ID: 10821403 [TBL] [Abstract][Full Text] [Related]
24. A new hydride generation system applied in determination of arsenic species with ion chromatography-hydride generation-atomic fluorescence spectrometry (IC-HG-AFS). Wei C; Liu J Talanta; 2007 Sep; 73(3):540-5. PubMed ID: 19073068 [TBL] [Abstract][Full Text] [Related]
25. Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide. Zheng Y; Mao YF; Zhao HJ; Chen L; Wang LN; Zhang YX; Hu J; Li JM; Li XY; Zhu HM Exp Hematol Oncol; 2021 Feb; 10(1):10. PubMed ID: 33549147 [TBL] [Abstract][Full Text] [Related]
26. [Simultaneous speciation of arsenic and selenium by high performance liquid chromatography-double channel atomic fluorescence spectrometry]. Wang Z; He B; Shi J; Yin Y; Jiang G Se Pu; 2009 Sep; 27(5):711-6. PubMed ID: 20073208 [TBL] [Abstract][Full Text] [Related]
27. Torsemide increases arsenic concentrations by inhibition of multidrug resistance protein 4 in arsenic trioxide treated acute promyelocytic leukemia patients. Lv J; Wu M; Pang C; Duan R; Zhang H; Tian S; Yang H; Hai X Biomed Pharmacother; 2023 Jul; 163():114858. PubMed ID: 37172335 [TBL] [Abstract][Full Text] [Related]
28. Impact of arsenic in foodstuffs on the people living in the arsenic-affected areas of West Bengal, India. Mandal BK; Suzuki KT; Anzai K J Environ Sci Health A Tox Hazard Subst Environ Eng; 2007 Oct; 42(12):1741-52. PubMed ID: 17952775 [TBL] [Abstract][Full Text] [Related]
29. Speciation of arsenic trioxide metabolites in peripheral blood and bone marrow from an acute promyelocytic leukemia patient. Iriyama N; Yoshino Y; Yuan B; Horikoshi A; Hirabayashi Y; Hatta Y; Toyoda H; Takeuchi J J Hematol Oncol; 2012 Jan; 5():1. PubMed ID: 22272800 [TBL] [Abstract][Full Text] [Related]
30. Effect of arsenosugar ingestion on urinary arsenic speciation. Ma M; Le XC Clin Chem; 1998 Mar; 44(3):539-50. PubMed ID: 9510859 [TBL] [Abstract][Full Text] [Related]
31. Stability study of As(III), As(V), MMA and DMA by anion exchange chromatography and HG-AFS in wastewater samples. Segura M; Muñoz J; Madrid Y; Cámara C Anal Bioanal Chem; 2002 Oct; 374(3):513-9. PubMed ID: 12373402 [TBL] [Abstract][Full Text] [Related]
32. Stability, preservation and storage of As(iii), DMA, MMA and As(v) in water samples. Brombach CC; Lancaster ST; Dexter MA; Thompson KC; Corns WT Anal Methods; 2021 Jul; 13(28):3154-3159. PubMed ID: 34164635 [TBL] [Abstract][Full Text] [Related]
33. Arsenic methylation metabolism and liver injury of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment. Wang H; Xi S; Liu Z; Yang Y; Zheng Q; Wang F; Xu Y; Wang Y; Zheng Y; Sun G Environ Toxicol; 2013 May; 28(5):267-75. PubMed ID: 23589229 [TBL] [Abstract][Full Text] [Related]
34. Complementary chromatography separation combined with hydride generation-inductively coupled plasma mass spectrometry for arsenic speciation in human urine. Chen LW; Lu X; Le XC Anal Chim Acta; 2010 Aug; 675(1):71-5. PubMed ID: 20708119 [TBL] [Abstract][Full Text] [Related]
35. Methylated arsenic metabolites bind to PML protein but do not induce cellular differentiation and PML-RARα protein degradation. Wang QQ; Zhou XY; Zhang YF; Bu N; Zhou J; Cao FL; Naranmandura H Oncotarget; 2015 Sep; 6(28):25646-59. PubMed ID: 26213848 [TBL] [Abstract][Full Text] [Related]
37. Determination of arsenic metabolic complex excreted in human urine after administration of sodium 2,3-dimercapto-1-propane sulfonate. Gong Z; Jiang G; Cullen WR; Aposhian HV; Le XC Chem Res Toxicol; 2002 Oct; 15(10):1318-23. PubMed ID: 12387631 [TBL] [Abstract][Full Text] [Related]
39. Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine. Le XC; Ma M; Cullen WR; Aposhian HV; Lu X; Zheng B Environ Health Perspect; 2000 Nov; 108(11):1015-8. PubMed ID: 11102289 [TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetic properties of arsenic species after oral administration of Sargassum pallidum extract in rats using an HPLC-HG-AFS method. Cao Y; Duan J; Guo J; Li W; Tao W J Pharm Biomed Anal; 2014 Aug; 96():213-9. PubMed ID: 24763266 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]